Clair Health

Pioneering continuous hormone intelligence.

San Francisco, United States · Founded 2025 · $11.6M raised

Employees
1–10
Founded
2025
Business Model
B2C
Total Funding
$11.6M
Last Round
$11.6M SeedJun 2026
Rounds
1

About

Clair Health is a San Francisco-based women's health startup building the world's first noninvasive continuous hormone monitor, a wrist-worn wearable device that tracks estrogen, progesterone, LH, FSH, and PdG in real-time. Founded in 2025 by Stanford graduates Jenny Duan (CEO) and Abhinav Agarwal, Clair uses 10 biosensors and over 130 proprietary biomarkers to give women continuous, on-device hormone intelligence without needles or test strips. In June 2026, the company raised $11.6 million in seed funding led by Khosla Ventures to advance clinical validation and bring the device to market.

Summary

Clair Health is a Biotech company based in San Francisco, United States, founded in 2025. It has raised $11.6M in total across 1 round, most recently a $11.6M Seed round in Jun 2026. Investors include Khosla Ventures, Reach Capital and Anne Wojcicki.

Tech & App Stack

2 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundJun 2026
$11.6M

Investors

Similar Companies